Article citationsMore>>

Vogel, M., Hämmig, R., Kemter, A., Strasser, J., von Bardeleben, U., Gugger, B., et al. (2016) Use of Microdoses for Induction of Buprenorphine Treatment with Overlapping Full Opioid Agonist Use: The “Bernese Method”. Substance Abuse and Rehabilitation, 7, 99-105.
https://doi.org/10.2147/sar.s109919

has been cited by the following article:

• TITLE: Rapid Buprenorphine Micro-Induction in Pregnant Patients with Opioid Use Disorder: A Retrospective Cohort Study

  AUTHORS: Jordan Needens, Rebecca Hicks, Emily Sloane, Laurel Thomas, Melissa Niehls, Kate Billups, Taylor Burke, Michael Derosa, David Chaffin, Jesse Cottrell

  KEYWORDS: Pregnancy, Opioid Use Disorder, Buprenorphine, Micro-Induction, Substance Abuse

  JOURNAL NAME: Open Journal of Obstetrics and Gynecology, Vol.16 No.10, October 14, 2026

  ABSTRACT: We aimed to evaluate whether a rapid buprenorphine micro-induction protocol reduces hospital length of stay and readmission rates in pregnant patients with opioid use disorder (OUD). A retrospective cohort study of pregnant patients with OUD admitted between January 2020 and December 2021 was performed. Primary outcomes were hospital length of stay and readmission rates. Ninety-eight patients were included. Forty-five (45.9%) underwent rapid buprenorphine micro-induction. Mean hospital length of stay was 2.63 ± 1.95 days in the rapid induction group compared with 3.37 ± 4.96 days in historical controls. Readmission rates were 20% in the rapid induction cohort versus 63.6% in traditional induction groups. Rapid buprenorphine micro-induction was associated with clinically meaningful reductions in hospital length of stay and readmission rates in pregnant patients with OUD.